MVR- T7011

N/A

Report date: 2025/02/13 14:24:00

Base Information

Drug NameMVR- T7011
Drug Alias NameMVR- T7011
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionB-lymphocyte antigen CD19 gene transferenceB-cell maturation protein gene transferenceC-C motif chemokine 5 gene transference +[5] 
TargetsB-lymphocyte antigen CD19B-cell maturation proteinC-C motif chemokine 5 +[5] 
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesImmvira Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesImmvira Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A